[PDF][PDF] Economic evaluation of dabigatran etexilate in the management of atrial fibrillation in Greece
GK Andrikopoulos, V Fragoulakis… - Hellenic J …, 2013 - researchgate.net
… To guide efficient resource allocation, an economic evaluation was … in the management
of AF patients in Greece and the present paper presents the results of this economic analysis. …
of AF patients in Greece and the present paper presents the results of this economic analysis. …
PCV77 Economic Evaluation of Dabigatran Etexilate 150dib for the Stroke Prevention in Atrial Fibrillation in Greece: A Cost–Effectiveness Analysis under the Greek …
V Fragoulakis, T Theodoratou… - Value in …, 2011 - valueinhealthjournal.com
… Dabigatran etexilate may represent a cost-effective choice for the management of patients
with atrial fibrillation in Greece… conduct an economic analysis comparing treatment with clopi…
with atrial fibrillation in Greece… conduct an economic analysis comparing treatment with clopi…
The Gap between economic evaluations and clinical practice: a systematic review of economic evaluations on dabigatran for atrial fibrillation
HJA Rolden, GJ van der Wilt, AHEM Maas… - … Assessment in Health …, 2018 - cambridge.org
… In conclusion, model-based economic evaluations on dabigatran vs. VKAs for the … Economic
evaluation of dabigatran etexilate in the management of atrial fibrillation in Greece. Hellenic …
evaluation of dabigatran etexilate in the management of atrial fibrillation in Greece. Hellenic …
[HTML][HTML] Review of cost-effectiveness of antithrombotic alternatives in patients with atrial fibrillation
J Cruz, LO Barros, SSF Morais… - Revista da Associação …, 2021 - SciELO Brasil
… in patients with atrial fibrillation: a Greek perspective. Am J Cardiovasc Drugs. 2017;17(2):123-33. …
This model is used for economic evaluations in healthcare systems, considering the …
This model is used for economic evaluations in healthcare systems, considering the …
Economic evaluation of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) for stroke prevention in patients with atrial fibrillation: a systematic …
R Noviyani, S Youngkong, S Nathisuwan… - BMJ Evidence-Based …, 2022 - ebm.bmj.com
… . Economic evaluation of dabigatran etexilate in the management of atrial fibrillation in
Greece. Hellenic J Cardiol 2013;54:289–300.pmid:http://www.ncbi.nlm.nih.gov/pubmed/…
Greece. Hellenic J Cardiol 2013;54:289–300.pmid:http://www.ncbi.nlm.nih.gov/pubmed/…
[PDF][PDF] The assessment of the Quality of Life in patients with atrial fibrillation, treated with dabigatran vs acenocoumarol; A prospective study
T Soultana, K Maria, K Maria - scienpress.com
… Last but not least, the economic impact of drug administration in Greece of economic crisis is
major. In a study of Andrikopoulos et al. … Economic Evaluation of Dabigatran Etexilate in the …
major. In a study of Andrikopoulos et al. … Economic Evaluation of Dabigatran Etexilate in the …
PCV79 Economic Evaluation of Rosuvastatin Versus Atorvastatin, Simvastatin and Pravastatin in High Risk Patients Treated for Primary and Secondary Prevention of …
V Fragoulakis, G Kourlaba… - Value in Health, 2011 - valueinhealthjournal.com
… Dabigatran etexilate may represent a cost-effective choice for the management of patients
with atrial fibrillation in Greece… conduct an economic analysis comparing treatment with clopi…
with atrial fibrillation in Greece… conduct an economic analysis comparing treatment with clopi…
[PDF][PDF] Novel oral anticoagulants in atrial fibrillation: will the benefit outweigh the cost
J Goudevenos, A Pipilis, P Vardas - Hellenic J Cardiol, 2012 - hellenicjcardiol.org
… Status of anticoagulation therapy for patients with atrial fibrillation in north-western Greece.
… of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: …
… of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: …
[HTML][HTML] Cost effectiveness of patient self-managed warfarin compared with direct oral anticoagulants in atrial fibrillation: an economic evaluation in a Danish …
… analysis, the same distribution of DOAC use was assumed. Daily doses of dabigatran
etexilate … (For elaboration of the estimation of costs associated with PSM and DOAC treatment, …
etexilate … (For elaboration of the estimation of costs associated with PSM and DOAC treatment, …
Apixaban, dabigatran, and rivaroxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation: a cost-effectiveness analysis
… economic impact of NOAs for stroke prevention before their introduction, but, in the Italian
setting, a comprehensive comparative analysis and a full economic evaluation … the economic …
setting, a comprehensive comparative analysis and a full economic evaluation … the economic …